-
MEMBER INFORMATION
Our website is now a subscription based members only website. 95% of our website requires a donation of a minimum of $2/month so we can keep this website going. Guests can only view about 5% of our website. Please register and donate a minimum of $2 for a one month subscription. Thanks for your donation!
If you are a RRDi inactive member, you need to login to your account. Then simply accept the new terms of registration and subscribe for a minimum of one month (discount for three, six, twelve, or hundred twenty month subscriptions). That reactivates your account. Once you are reactivated, under your display name it shows 'Active Member Subscribed.' This gives you a minimum of 30 days of access to our website with 95% of our rosacea data (longer if you choose a longer subscription plan). Guests and inactive members are restricted and can only view a small percentage of free rosacea information data.
If you remember the email address you used to register your account but forgot the password, use the forgot password tool to reactivate your account:
https://irosacea.org/lostpassword/
If you don't remember your login credentials, our volunteers can assist. Use the contact form and give us what you remember you used to register your account, i.e., your display name? We can investigate and try to locate the account you registered and then reset your password for you based upon what EMAIL you used to register your account (or give us a current email address to update your account).
Did you experience landing on a an error code message?
Watch two short videos that explain why.Read below for detailed information for Guests and Inactive Members.
In the past we allowed guests to read certain forums that contain a huge database of rosacea information which used to be free. If you see an error code message that means we encourage you to join the RRDi to view what you are searching for. Without a doubt you will be encouraged by what you read once you become a member of our non profit grassroots organization for rosacea. Membership requires a minimum donation of $2/month for a subscription (discounts for three or more months).
Guests and Inactive Members Have Limited Access to the RRDi Website
Certain Member Forums are no longer open to the public any more and are for members only. If you are seeing error code messages it imay be because the following forums do not allow guests any more (as of February 24, 2021). As a guest you are allowed to view certain pages and posts on our website. Below are the lists of forums open to guests and inactive registered members and areas of the website open to registered active members:Areas of the website open to guests and inactive registered members.
Areas of the website open to active registered members.
Guests are not allowed to post since the end of June 2022.
Watch two short videos that explain all this.
Members
Inactive Members Have Limited Access to the RRDi Website and are only allowed to visit the website guests are able to view.
Members who are seeing error code messages should read this announcement about ACTIVE or INACTIVE MEMBERS.All Forums are Available if you Join the RRDi and become a Member. If you are inactive. Please donate two dollars so we can keep this website going! Or donate three dollars and get three months access to our rosacea data to research and investigate rosacea. Join fellow rosaceans and support each other.
New Registrations
All new registrations require a subscription which starts the approval process for security purposes and registration. You may also use Sign in with Apple, Facebook, Google, or Microsoft.How to Register
1) First you need to Register at: https://irosacea.org/register
a) Choose a subscription plan and use your email address or Sign up with Sign in the Apple, Facebook, Google, or Microsoft
b) Use a cryptic display name you choose if you want to remain private
c) You may choose any subscription plan and only use it for the minimum number of months and then cancel your subscription. The minimum is $2 for one month or discounts for three, six, twelve, or 120 months ($1 a month). You may cancel your subscription at any time you choose but the one month subscription plan requires a minimum amount of $2. The three month requires a minimum of $3....and so on.
d) type in your acceptance of the terms by typing in YES or Yes in the box (proves you are a human, not a robot)
f) check the box 'I agree to the Terms of Use and Privacy Policy' (proves you are a human, not a robot)
If you have any issues with the above instructions and find our subscription sign up wanting or need assistance, please contact us and explain your issues. You are required to give us your email address to be able to reply to any concern you may have.Inactive Members
First search our list of members to see if you are listed as inactive. You may be an inactive voting member which requires a different search. We no longer allow free members unless you are on the staff, or a MAC Member, Grant Writer, Proof Reader, or one of our volunteers.
If you are having issues logging into your account, contact us. Or simply login and subscribe to one of our subscription plans to be active again. Learn More! • Our volunteers will be happy to assist you if you hare having any issues logging in to your account. Use the contact form explaining your issue.
Non Voting Members
We are not allowing non voting members to gain access to our website and all non voting members must choose a subscription plan to enter our website.Most Private and Secure Registration
Sign in with Apple is the most private and secure registration and can learn more here.Voting Members Are Special
However to be a voting member you must join the RRDi and subscribe to identify yourself when registering with your contact information to be able to vote who sits on the board of directors. You are not required to be a voting member. The RRDi will never reveal your identity to anyone so you can rest assured our privacy policy is solid. You may want to read this post, entitled, Anonymity, Transparency and Posting.Members can also post articles on rosacea which may be used later for publication either on our web site as a promoted article [see some of our member published articles] or as an article in a future publication of the Journal of the RRDi. There is also a member Blogs Area and member Gallery Area for your use if you join the RRDi. Also, ask about a free G Suite account available if you volunteer with our non profit organization (mention you want to volunteer when you join). Volunteers may have subscriptions plans waived. We cordially invite you to join whether or not you can volunteer or post in our Member Forum which is a private forum. Increasing our membership shows you care about rosacea sufferers.
Mobile App
We need volunteer beta testers who are developers (using the Invision Community app) to create an RRDi app for iOS or Android. If you want to volunteer learn more by reading this post. If you have any questions, contact us • An Invision Community iOS was available in beta with some issues and now the android app is similar.
-
Guest Forum
Posting Requires Subscription -
Activity Stream
-
0
PubMed RSS Feed - -Characteristics of Rosacea and Similar Diseases in Patients Wearing Face Masks
Skin Appendage Disord. 2022 Nov;8(6):462-468. doi: 10.1159/000525024. Epub 2022 Jun 7. ABSTRACT INTRODUCTION: The present study aimed to obtain fundamental data, including climate conditions and Demodex mites, on rosacea and similar diseases in the situation where the wearing of face masks is mandatory due to the coronavirus disease 2019 pandemic. METHODS: We enrolled 86 Japanese patients habitually wearing face masks with rosacea and similar diseases. Disease severity was assessed using the Investigator Global Assessment. The presence of Demodex mites was examined microscopically. Treatment involved acaricidal and antibiotic agents. RESULTS: The numbers of male and female patients enrolled were 11 and 75, respectively. Among these patients, 85 (98.8%), 57 (66.3%), and 76 (88.4%) had rosacea, rosacea-like dermatitis (RLD), and demodicosis, respectively. The monthly number of patients with rosacea and demodicosis showed two peaks from May to June and in October, during which monthly mean temperature was approximately 20°C (68°F). Improvement rates in rosacea, RLD, and demodicosis were significantly higher when Demodex mites were no longer detected after treatment. CONCLUSION: The present results suggest that a season with a mean temperature of approximately 20°C is a risk factor for rosacea and similar diseases in individuals wearing face masks in Japan, and a decrease in Demodex mites is associated with the attenuation of symptoms. PMID:36407649 | PMC:PMC9672874 | DOI:10.1159/000525024 {url} = URL to article -
0
PubMed RSS Feed - -Chemical peel as an adjuvant treatment in pigmented contact dermatitis: a case series
J Cosmet Laser Ther. 2022 Nov 17:1-6. doi: 10.1080/14764172.2022.2147953. Online ahead of print. ABSTRACT A chemical peel is chemexfoliation, a process of application of a chemical substance to the skin that causes controlled chemical destruction of the epidermis with or without part of the dermis leading to skin regeneration and remodeling. It can be classified depending upon the depth of penetration into superficial, medium, and deep peels. Among various indications, peels can be used to enhance treatment within a variety of conditions including skin- rejuvenation, inflammatory disorders like acne, rosacea, acne scar, and pigmentary disorders like melasma, freckles, lentigens, dyschromia, and post-inflammatory pigmentation. We did a chemical peel for six patients with facial melanosis, diagnosed with Riehl melanosis. All patients had visible clinical improvement. Detailed history and informed consent were taken both for photographs and procedures from all patients. PMID:36384385 | DOI:10.1080/14764172.2022.2147953 {url} = URL to article -
0
PubMed RSS Feed - -Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity
J Clin Aesthet Dermatol. 2022 Nov;15(11):69-74. ABSTRACT OBJECTIVE: Subantibiotic dose doxycycline (SDD40), formulated as a modified-release 40mg capsule administered once daily, is used to treat inflammatory lesions of rosacea. In order to investigate whether the patient's weight or lesion severity impacts clinical outcomes with using SDD40, the efficacy and safety of SDD40 in treating rosacea were evaluated in randomized controlled studies (RCTs). METHODS: Phase II, III, and IV RCTs, and a subsequent meta-analysis were described. For all studies, the primary efficacy endpoint was the change in total inflammatory lesion count (papules, pustules, and nodules) from baseline to Week 16. For one of the studies, body weights were categorized by BMI (body mass index). Secondary efficacy endpoints included the change in Investigator's Global Assessment (IGA). Safety was assessed by monitoring adverse events (AEs). RESULTS: The efficacy of SDD40 was consistent across the studies (two trials including n=72 and n=91 subjects) and meta-analysis (n=127 and n=142). SDD40 remained effective regardless of baseline disease severity and weight (with a weak correlation coefficient below 0.75); overweight or obese subjects with severe rosacea cleared at least as well if not better than those with a normal BMI and mild disease. The treatment was well tolerated with no to minimal gastrointestinal-related AEs. LIMITATIONS: Retrospective analyses have methodological limitations. CONCLUSION: Consistency between study results including the meta-analysis supports the effectiveness and safety of SDD40, irrespective of the weight of the patient or rosacea severity based on inflammatory lesion count at baseline. PMID:36381182 | PMC:PMC9651154 {url} = URL to article -
0
PubMed RSS Feed - -Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis
Transl Vis Sci Technol. 2022 Nov 1;11(11):13. doi: 10.1167/tvst.11.11.13. ABSTRACT PURPOSE: Dry eye disease (DED) is a heterogeneous condition with poorly characterized subtypes. The DREAM study was a large multicenter randomized clinical trial that did not find omega-3 to be more effective than placebo in treating symptomatic DED. We performed secondary analysis of DREAM data to characterize DED subtypes and their omega-3 response. METHODS: A total of 535 patients with moderate-to-severe DED were randomized to omega-3 or placebo treatment for one year. We used latent profile analysis to identify subtypes based on baseline Ocular Surface Disease Index, tear break-up time (TBUT), anesthetized Schirmer's test, corneal and conjunctival staining, and meibomian gland dysfunction (MGD). We evaluated omega-3's effect for each subtype using generalized linear regression. RESULTS: Five clinically meaningful DED subtypes were identified. They differed significantly in sex (P < 0.001) and race (P = 0.02). Subtype 1 had the most severe DED signs yet milder symptoms and was associated with more Sjögren's syndrome (21%, P < 0.001). Subtype 2 had the mildest DED signs except MGD. Subtype 3 had the most severe symptoms, out of proportion to DED signs. Subtype 4 had relatively milder symptoms and MGD. Subtype 5 had severe MGD and TBUT and was associated with rosacea (29%, P = 0.04). Omega-3 was not significantly more beneficial than placebo for any subtype. CONCLUSIONS: Five clinically meaningful DED subtypes differed significantly in demographics, symptoms, signs, and systemic disease associations. Omega-3 was not significantly more effective than placebo for any subtype. TRANSLATIONAL RELEVANCE: T3 translational research identifying subtypes in the DREAM study can improve DED clinical classification and targeted management. PMID:36383391 | DOI:10.1167/tvst.11.11.13 {url} = URL to article -
0
Active Members Posting
We do have a few active members now who have subscribed. We need about 100 members who subscribe to keep this website going which means keeping the RRDi going. Why we chose the subscription vs the freemium version of using our website is explained here. The active members still do not post which is not a requirement, the only requirement is to subscribe. Do you have any comment and wish to post about any of this? You can post for a minimum of a two dollar subscription or if you just donate two dollars we can make you an active member for one month so you can post for a month. You simply donate through a multitude of services listed on our donation page and then CONTACT us explaining you made a minimum two dollar donation and we can activate your membership for a month (or longer if you donate more). If you don't like subscriptions, why not post and explain how we should be operating our website. Your comment could be published in this thread, ACTIVE MEMBERS POSTING, or anywhere you want to post on our website. Maybe you have some insight into why our ACTIVE members don't post at all? Even if you are a volunteer and don't post you become inactive. Read more.
-
-
Member Statistics
